
FDA grants accelerated approval to rucaparib for BRCA-mutated metastatic castration-resistant prostate cancer
The Food and Drug Administration (FDA) granted accelerated approval to rucaparib for patients with deleterious…
The Food and Drug Administration (FDA) granted accelerated approval to rucaparib for patients with deleterious…